Marinus Pharmaceuticals

NasdaqGM:MRNS Stock Report

Mkt Cap: US$223.8m

Marinus Pharmaceuticals Future Growth

How is Marinus Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

[object Object] Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


19.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:MRNS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202453-141-96N/A7
12/31/202330-151-131-16610
12/31/202227-14-100-9310
9/30/202220-14-115-113N/A
6/30/202228-105-80-78N/A
3/31/202228-91-69-67N/A
12/31/202115-99-58-55N/A
9/30/202115-88-52-50N/A
6/30/20215-84-71-70N/A
3/31/20214-76-63-63N/A
12/31/20202-76-61-61N/A
9/30/20200-74-61-61N/A
6/30/2020N/A-72-58-58N/A
3/31/2020N/A-69-51-51N/A
12/31/2019N/A-54-49-49N/A
9/30/2019N/A-49-42-42N/A
6/30/2019N/A-46-37-36N/A
3/31/2019N/A-43-34-33N/A
12/31/2018N/A-37-28-28N/A
9/30/2018N/A-31-23-23N/A
6/30/2018N/A-24-20-19N/A
3/31/2018N/A-19-18-18N/A
12/31/2017N/A-19-19-19N/A
9/30/2017N/A-20-21-20N/A
6/30/2017N/A-22-24-24N/A
3/31/2017N/A-27-26-26N/A
12/31/2016N/A-29-25-25N/A
9/30/2016N/A-30-24-24N/A
6/30/2016N/A-29N/A-23N/A
3/31/2016N/A-25N/A-22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MRNS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MRNS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MRNS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MRNS's revenue (63% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: MRNS's revenue (63% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MRNS's Return on Equity is forecast to be high in 3 years time


Discover growth companies